#ISGD
#ISGDCTS2026 Awards Ceremony 🏆
🌟 Louise Oni: Mid-Career Achievement Award
🌟 Aliza Thompson: Lifetime Achievement Award (joined virtually!)

Congratulations 🎉
Thank you for your excellence and real-life impact in #GlomerularDisease

@Tobias_B_Huber
#ISGD #ClinicalTrials #NephTwitte
November 15, 2026 at 3:57 PM
🔥 Lesley Inker brilliant talk about hierarchical composite endpoints for #GlomerularDisease
The future of clinical trials? 🔜

tobias-b-huber.bsky.social kidney.org
#ISGDCTS2026 #ISGD #ClinicalTrials #Nephrology
November 14, 2026 at 8:57 PM
Published simultaneously with ISGD Clinical Trials Summit 2026, a #ASNJASN study found that finerenone preserved kidney function and produced clinically meaningful reductions in proteinuria in participants with FSGS in FIND-CKD. kidney.pub/JASN1333
November 15, 2026 at 7:00 PM
Outstanding by Priya Verghese 🔥
‼️ In post-transplant recurrent GN research, feasibility is not secondary. It is scientific rigor.
The rarity of a condition should never determine the quality of evidence! 🌟

tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials
November 14, 2026 at 4:35 PM
🔥 Stimulating roundtable for both brain and kidneys 🧠
🤯 Brain capital, health span and more! By @JochenReiser, @MitchElkind, Mikele Epperly and Peter McCaffrey

tobias-b-huber.bsky.social utmbhealth.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nephrology
November 14, 2026 at 10:19 PM
Exciting news! ISGD joins NKF and NephCure in a new KidneyCARE Study partnership to amplify patient voices and advance glomerular disease research.

Read the announcement: www.kidney.org/press-room/n...
November 18, 2026 at 7:53 PM
🚨 ISGD announces the first-of-its-kind partnership!
ISGD 🤝 Qualified Health
The first AI-enabled research network!

The future is here.
We are the doers.

tobias-b-huber.bsky.social utmbhealth.bsky.social
#CTS2026 #ISGD #GlomerularDisease #ClinicalTrials #AI #NephTwitter #Nephrology
November 13, 2026 at 6:25 PM
Addressing unmet needs in Pediatric Nephrology by @louiseoni.bsky.social🌟
🌎 New world for children with #GlomerularDisease! No more waiting 13+ years after adult drug approval 👋

tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #ClinicalTrials #Nephrology #PediatricNephrology
November 14, 2026 at 4:17 PM
Wrapping up Day 2 with a packed Poster session at the #ISGDCTS2026 🔥

If you're attending, which ones were your favorites? 🌟
If not, what research would you like to see? 🔎

tobias-b-huber.bsky.social
#ISGD #GlomerularDisease #ClinicalTrials #Nephrology
November 15, 2026 at 12:50 AM
November 13, 2026 at 4:00 PM
Breathtaking interactive roundtable 🔥 Kirk Campbell, Heedo Heerspink, Vlado Perkovic and Katherine Tuttle discuss lessons learned from the last generation of clinical trials, and the road ahead! 🔜

#CTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nephrology
tobias-b-huber.bsky.social
November 13, 2026 at 8:32 PM
November 13, 2026 at 4:00 PM
Closing Day 1: Voice of VCs — Sahir Ali, Mohsin Khan and Michael Torres.
Investors help decide which mechanism becomes a medicine, by criteria scientists rarely see.
Uncomfortable? Worth hearing 🌟

#CTS2026 #ISGD #GlomerularDisease #Biotech #ClinicalTrials
tobias-b-huber.bsky.social
November 13, 2026 at 11:48 PM
🚨 Wrapping up #ISGDCTS2026 with fresh news! 🚨
🤯 Groundbreaking partnership

isgd.bsky.social 🤝 glomcon.org
✨ The Centers of Excellence in #GlomerularDisease

tobias-b-huber.bsky.social Ali Poyan Mehr
#CoEGD #ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nephrology
November 15, 2026 at 6:56 PM
🚨 Late Breaking Research #4
🔥 Amazing results presented by Jonathan Barratt on the PIONEER study for IgAN and pMN!
👇 Check below

tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nephrology
November 15, 2026 at 6:02 PM
🚨 Late Breaking Research #2
Fantastic results presented by Matthew Renfrow! 🔥
🔛 The bidirectional influence between Gd-IgA1 and kidney outcomes!

tobias-b-huber.bsky.social CureGN
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials #NephTwitter #Nephrology
November 15, 2026 at 5:39 PM
November 13, 2026 at 4:40 PM
Fantastic innovative roundtable featuring Erika Allred, Sweta Sinha and Bill Smoyer

💥 Breaking barriers
🚀 From challenges to solutions
🌟 Bright and exciting future!

Follow us, stay tuned!

tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nephrology
November 15, 2026 at 6:33 PM
🚨 Late Breaking Research #3
🌟 Fantastic talk by Abigail Smith!
👉 The promising role of eGFR and proteinuria as surrogate markers in APOL1 kidney disease

tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials #NephTwitter #Nephrology
November 15, 2026 at 5:50 PM
Interactive roundtable with Pharmaceutical partners 💫
🧩 Challenges, barriers and future solutions
Rob Brenner, @InrigJula, Jiahua Li guided by Uptal Patel

👇 Drop your questions below

tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nephrology
November 15, 2026 at 6:48 PM
🔥 Meeting practical needs and optimizing trial design in #GlomerularDisease by Hiddo Heerspink!
Which trial is best for which disease and context? 🔎

tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #ClinicalTrials #NephTwitter #Nephrology
November 14, 2026 at 3:56 PM
🚨 Late Breaking Research #5
🌟 Brilliant by Brendon Neuen
Much needed analysis from a fantastic collaborative SLR/MA

🤯 Another simultaneous article! In press at Nature Medicine
Slides at clarity-igan.org

tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nep
November 15, 2026 at 6:20 PM
🔥 Eloise Salmon perfectly explored patient-reported outcomes (PROs) and the PREPARE-NS project! 🔜
Bringing patients voice into clinical trials is crucial 🌟

tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nephrology
November 14, 2026 at 9:14 PM
🚨 Late Breaking #1
🌟 Hiddo Heerspink on finerenone in FSGS (FIND-CKD): see albuminuria and proteinuria 🔎
👉 https://journals.lww.com/jasn/pdf/10.1681/asn.0000001333~finerenone-in-patients-with-focal-segmental
tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrial
November 15, 2026 at 5:26 PM